Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Ergotamine product |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Product containing ergotamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Product containing ergotamine tartrate |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine tartrate (substance) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Caffeine + ergotamine tartrate |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator (substance) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Product containing caffeine and ergotamine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Analgesic (substance) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has manufactured dose form |
Rectal dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Caffeine-containing product in rectal dose form |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has manufactured dose form |
Rectal suppository |
true |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine (substance) |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute specifies the denominator unit for the presentation strength of a product. |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has unit of presentation |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute specifies the denominator unit for the presentation strength of a product. |
Suppository (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has presentation strength numerator value |
deux |
false |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Caffeine |
true |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Caffeine |
true |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Ergotamine tartrate (substance) |
true |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Ergotamine tartrate (substance) |
true |
Inferred relationship |
Some |
2 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Has presentation strength numerator value |
10^2 |
false |
Inferred relationship |
Some |
1 |
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Is a |
Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository |
Plays role |
Antimigraine therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|